AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BUSINESS BRIEFS.(TO THE POINT)
MEDICAL
FDA OKs Pfizer nerve pain drug
Lyrica, which eases sharp pains in the extremities related to diabetes or shingles, will be marketed to about 3 mil U.S. diabetics who will develop nerve damage and an estimated 150,000 shingles sufferers. Pfizer, which is grappling with fall-out from its Celebrex painkiller's raised cardio risks, said the drug's safety was tested with 9,000 patients. Shares fell 0.5% to 26.89.
Congressman probing Lilly docs
The British Medical Journal gave the FDA and Rep. Maurice Hinchey, D-N.Y., confidential Eli Lilly documents suggesting a link between the antidepressant Prozac and a risk of suicide attempts and violence. The publication got the papers, allegedly missing for 10 years, from an anonymous source. Lilly claims docs never went missing, and Prozac's safety is ...
- FDA OKs immune therapy. (For chronic hereditary immune disorder)
- Press release article from: PR Newswire December 21, 1990 700+ words
FDA OKS IMMUNE THERAPY WASHINGTON, Dec. 21 /PRNewswire/ -- The Food and Drug Administration today announced approval of a treatment...
- FDA OKs Randomized Trial to Support Proposed Indication for Clolar in Adult AML
- Newspaper article from: Wireless News September 3, 2009 700+ words
Wireless News 09-03-2009 FDA OKs Randomized Trial to Support Proposed Indication for Clolar in Adult AML Type: News Genzyme Corp. announced that the FDA's Oncologic...
- FDA OKs Genzyme's Epicel skin graft product for burns.
- Newspaper article from: Medical Device Daily October 30, 2007 700+ words
FDA OKs Genzyme?s Epicel skin graft product for burns By DONNA YOUNG Medical Device Daily Contributing Writer The FDA has approved Genzyme...
- FDA OKs IDE for trial of C-Pulse in moderate heart failure patients.
- Newspaper article from: Medical Device Daily September 18, 2008 700+ words
FDA OKs IDE for trial of C-Pulse in moderate heart failure patients By LYNN YOFFEE Medical Device Daily Staff Writer Patients with heart...
- FDA OKs Avastin for the Most Common Type of Kidney Cancer
- Newspaper article from: Wireless News August 7, 2009 700+ words
Wireless News 08-07-2009 FDA OKs Avastin for the Most Common Type of Kidney Cancer Type: News Genentech, Inc., a member of the Roche Group announced that the...
- FDA OKs Bristol's Diabetes Drug - Analyst Blog
- Newspaper article from: Zacks Investment Research - Analyst Blog Zacks Equity Research August 3, 2009 700+ words
FDA OKs Bristol's Diabetes Drug - Analyst Blog We are pleased with the FDA’s approval of Bristol-Myers Squibb Co...
- FDA OKs Diagnostic Hybrids Release of Thyretain
- Newspaper article from: Wireless News August 25, 2009 700+ words
Wireless News 08-25-2009 FDA OKs Diagnostic Hybrids Release of Thyretain Type: News Diagnostic Hybrids announced the FDA clearance, for marketing under the 510...
- FDA OKs Boston Sci's FilterWire EZ embolic protection system.
- Newspaper article from: Medical Device Daily August 25, 2004 700+ words
FDA OKs Boston Scis FilterWire EZ embolic protection system By HOLLAND JOHNSON Medical Device Daily Associate Managing Editor Boston Scientific...